10/30/2024

Dextran Low Molecular Weight (Dextran 40), 10% Injection

Products Affected - Description

- Dextran 40, Pfizer, 10% in 500 mL 0.9% Sodium Chloride, 12 count, NDC 00409-7419-03
- Dextran 40, Pfizer, 10% in 500 mL 5% Dextrose, 12 count, NDC 00409-7418-03

Reason for the Shortage

- Pfizer has low molecular weight dextran on shortage due to manufacturing delays.

Available Products

- There are no presentations available

Estimated Resupply Dates

- Pfizer has 10% low molecular weight dextran in 5% dextrose 500 mL bags and 10% low molecular weight dextran in 0.9% sodium chloride 500 mL bags on back order and the company estimates a release date of January 2025.

Updated

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.